SWP
LSTA icon

Stratos Wealth Partners’s Lisata Therapeutics LSTA Stock Holding History

Stratos Wealth Partners’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed – – 1776
2018
Q3 		$0 Buy
+1
New +$82 ﹤0.01% 3018
2018
Q2 		– Sell
-1
Closed – – 1894
2018
Q1 		$0 Hold
1
– – ﹤0.01% 3174
2017
Q4 		$0 Buy
+1
New +$50 ﹤0.01% 2816

Other funds holding LSTA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TFO
Tarbox Family Office Newport Beach, California $616M AUM 18.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Stratos Wealth Partners's LSTA Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Lisata Therapeutics (LSTA) in Q4 2018, closing a stake of 1 share.

Stratos Wealth Partners first reported a position in LSTA in Q4 2017 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 27 funds tracked by Wall St. Rank hold LSTA as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Lisata Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 1 Lisata Therapeutics share in Q4 2018.
  • Stratos Wealth Partners first reported a position in Lisata Therapeutics in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Lisata Therapeutics position peaked at $0 in Q3 2018.
  • 27 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.